Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-thymocyte Globulins for GVHD Prophylaxis After HLA-matched Sibling Stem Cell Transplantation in Patients at 40 Years of Age or More With Hematological Malignancies

NCT01856803 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT01856803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01856803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-thymocyte Globulins for GVHD Prophylaxis After HLA-matched Sibling Stem Cell Transplantation in Patients at 40 Years of Age or More With Hematological Malignancies
Lead sponsor
Peking University People's Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2013
Completion date
June 30, 2019
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, gvhd, atg, transplantation